NCT04138758View on ClinicalTrials.gov

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

CompletedOBSERVATIONAL
Enrollment

42,953

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

November 4, 2019

Study Completion Date

November 4, 2019

Conditions
COPD
Interventions
DRUG

Tiotropium bromide + Olodaterol

Tiotropium bromide + Olodaterol

DRUG

LABA/ICS

Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)

Trial Locations (1)

02472

HealthCore, Inc., Watertown

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04138758 - Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS | Biotech Hunter | Biotech Hunter